EX-99 2 exhibit991release.htm EXHIBIT 99.1 Sun Healthcare Group, Inc

EXHIBIT 99.1

Sun Healthcare Group, Inc.
Posts Improved Year Over Year Results for the Third Quarter

Contact: Investor Inquiries (505) 468-2341
Media Inquiries (505) 468-4582

     Irvine, Calif. (Nov. 2, 2004) - Sun Healthcare Group, Inc. (NASDAQ: SUNH) today announced total net revenues of $204.5 million and net income of $0.8 million for the quarter ended Sept. 30, 2004 (net income of $0.05 per share on a fully diluted basis), compared with total net revenues of $203.4 million and net income of $39.1 million for the comparable quarter in 2003.

     The 2004 third-quarter net income from continuing operations was $7.7 million as compared to a net loss of $12.0 million from continuing operations for the same period in 2003. The 2004 third-quarter net income was positively impacted by $10.1 million of net adjustments, which was comprised of (i) an $11.9 million gain recorded as a cumulative effect of a change in accounting principle as a result of the consolidation of nine entities, as described below, (ii) a $1.5 million loss on sale of assets related primarily to the write-down of land and buildings held for sale, and (iii) a $0.3 million charge for restructuring costs. The 2003 third-quarter net loss included (i) a $4.1 million charge for restructuring costs, and (ii) a $0.7 million loss on sale of assets. The 2004 third-quarter EBITDAR for continuing operations was $12.6 million as compared to $8.8 million for continuing operations for the same period in 2003.

     As a result of the previously reported option agreements to purchase nine entities that collectively own nine facilities that the Company currently leases and operates in New Hampshire, Sun is required to consolidate those nine entities pursuant to FASB Interpretation No. 46 ("FIN 46"). The Company's consolidated assets and liabilities will increase by approximately $54.2 million and $41.2 million, respectively, based upon the fair value of the assets and liabilities of those nine entities as of Sept. 30, 2004. "Overall, the consolidation of the nine entities favorably impacts our financial statements," said Richard K. Matros, chairman and chief executive officer. "The consolidation resulted in a $13.1 million improvement in the balance sheet and a recurring positive quarterly EBITDA impact of approximately $0.8 million. Depreciation and interest charges associated with those nine entities totaled $1.3 million, which resulted in a quarterly net loss of approximately $0.5 million for those nine entities."

     On Nov. 1, 2004, Sun sold its clinical laboratory and radiology operations located in California for $0.5 million cash and a $2.8 million promissory note. Those operations contributed net revenues of $5.0 million and net operating losses of $3.0 million in the third-quarter of 2004. Net revenues and net losses for the nine months ended Sept. 30, 2004, for those operations were $11.6 million and $11.5 million, respectively. Net revenues and net operating losses for the three and nine month periods were reported as discontinued operations.


     On Nov. 1, 2004, Sun acquired a small home healthcare agency in southern California that will improve the Company's market strength in that geographic area.

     Sun reported net revenues of $619.6 million and a net loss of $2.4 million for the nine months ended Sept. 30, 2004, compared with total net revenues of $592.2 million and a net income of $14.3 million for the comparable period in 2003.

     The net income from continuing operations for the nine months ended Sept. 30, 2004 was $12.8 million as compared to a net loss of $25.6 million from continuing operations for the same period in 2003. The 2004 nine-month net income was positively impacted by $12.8 million of net adjustments, which was comprised of (i) an $11.9 million gain recorded as a cumulative effect of a change in accounting principle as a result of the consolidation of nine entities as described above, (ii) a $3.7 million forgiveness of debt related to the refinancing of six inpatient facilities, (iii) a $1.6 million charge for restructuring, and (iv) a $1.2 million loss related primarily to the write-down of land and buildings held for sale. The 2003 nine-month net loss included a $10.0 million charge for restructuring costs, offset by a $2.2 million gain on sale of assets. The EBITDAR for continuing operations for the nine months ended Sept. 30, 2004, was $45.1 million as compared to $32.6 million for the same period in 2003.

Operating Results

     Net revenues from the inpatient services operations, which comprised 72.4 percent of Sun's total revenue from continuing operations for the quarter ended Sept. 30, 2004, increased 5.9 percent from $139.6 million for the quarter ended Sept. 30, 2003, to $147.8 million for the same period in 2004. The revenue gain primarily results from higher per diem rates in all payor categories and an increase in Medicare patients. EBITDAR for the continuing operations of inpatient services increased 8.6% from $15.1 million for the quarter ended Sept. 30, 2003, to $16.4 million for the same period in 2004.

     Sun's net revenues from its continuing ancillary business operations, comprised primarily of SunDance Rehabilitation Corporation, CareerStaff Unlimited, Inc., SunPlus Home Health Services, Inc., and SunAlliance Healthcare Services, Inc., net of intersegment eliminations, decreased $7.2 million from $63.7 million for the quarter ended Sept. 30, 2003, to $56.5 million for the same period in 2004. EBITDAR for those operations decreased over the same period from $5.5 million to $4.5 million.

     "We are pleased with the performance in our largest and core segment of inpatient services operations. We continue to make improvements in that segment," said Matros. "In addition, we have increased our focus on our ancillary operations and believe that we have identified and are addressing the operational issues affecting those businesses, particularly SunDance and CareerStaff. Our rehabilitation therapy services are showing strong signs of recovery from disruptions related to the previously contemplated sale of SunDance. Effective Nov. 1, 2004, we hired a new president, Rick Peranton, for the CareerStaff operations and we expect to see gradual improvement in that segment. Overall, we believe we have a business strategy that will continue to improve operationally and provide opportunities for growth organically and via acquisition."

2


Earnings Guidance for 2004

     For the year ended Dec. 31, 2004, Sun expects that its total revenues from continuing operations will remain at approximately $840.0 million to $850.0 million due to the sale of the California clinical laboratory and radiology operations. EBITDAR from continuing operations is expected to increase to approximately $58.0 million to $62.0 million as compared to the $50.0 million to $55.0 million given previously. EBITDA from continuing operations is expected to increase to approximately $18.0 million to $20.0 million as compared to the $8.0 million to $10.0 million given previously. Company guidance for net earnings is impacted by higher than expected losses from its California clinical laboratory and radiology operations, which were sold on Nov. 1, 2004, and the addition of $2.6 million of depreciation and interest charges for the last two quarters of the year related to the FIN 46 consolidation. Taking these into consideration, the actual net loss could be $7.0 million to $5.0 million as compared to the $5.0 million to $3.0 million given previously. This guidance assumes, among other things, no acquisitions, a stable reimbursement environment and the divestiture of the remaining three long-term care facilities by year-end. Weighted shares outstanding for the year are expected to be 14.5 million. "We are pleased that our EBITDAR and EBITDA guidance for 2004 is stronger than initially expected as we have improved more quickly than we anticipated," said Matros.

Conference Call

     Sun's senior management will hold a conference call to discuss its third-quarter operating results on Thursday, Nov. 4, 2004, at 1 p.m. EST/ 10 a.m. PST. To listen to the conference call, dial (877) 516-8526 and refer to Sun Healthcare Group. A recording of the call will be available from 4 p.m. EST on Nov. 4, 2004, until midnight EST on Nov. 10, 2004, by calling (800) 642-1687 and using access code 1609127.

About Sun Healthcare Group, Inc.

     Sun Healthcare Group, Inc., with executive offices located in Irvine, California, owns SunBridge Healthcare Corporation and other affiliated companies that operate long-term and postacute care facilities in many states. In addition, the Sun Healthcare Group family of companies provides therapy through SunDance Rehabilitation Corporation, medical staffing through CareerStaff Unlimited, Inc., home care through SunPlus Home Health Services, Inc., and medical laboratory and mobile radiology services through SunAlliance Healthcare Services, Inc.

# # #

     Statements made in this release that are not historical facts may be "forward-looking" statements (as defined in the Private Securities Litigation Reform Act of 1995) that involve risks and uncertainties and are subject to change at any time. These forward-looking statements may include, but are not limited to, statements containing words such as "anticipate," "believe," "plan," "estimate," "expect," "hope," "intend," "may" and similar expressions. Factors that could cause actual results to differ materially include, but are not limited to, the following: continued compliance by the Company under its loan agreement; changes in Medicare and Medicaid reimbursements; efforts of third-party payors to control costs; the impact of federal and state regulations and investigations; changes in payor mix and payment methodologies; further consolidation of managed care organizations and other third-party payors; competition in our business; potential liability for losses not covered by, or in excess of, our insurance; competition for qualified staff in the healthcare industry; our ability to control operating costs, return to profitability and generate sufficient cash flow to meet operational and financial requirements; and the potential impact of an economic downturn or changes in the

3


 laws affecting our business in those markets in which we operate. More information on factors that could affect our business and financial results are included in our Annual Report on Form 10-K for the year ended Dec. 31, 2003, and other public filings made with the Securities and Exchange Commission, copies of which are available at Sun's web site, www.sunh.com.


     The forward-looking statements involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond our control. We caution investors that any forward-looking statements made by us are not guarantees of future performance. We disclaim any obligation to update any such factors or to announce publicly the results of any revisions to any of the forward-looking statements to reflect future events or developments.

4


SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

CONDENSED
CONSOLIDATED BALANCE SHEETS
(in thousands)

ASSETS

September 30, 2004

December 31, 2003

 

(unaudited)

 

(audited)

 

Current assets:

       

  Cash and cash equivalents

$                     28,946

$                     25,574

  Accounts receivable, net

96,780

109,775

  Restricted cash

26,024

 

33,699

 

  Other current assets

                    22,409

 

                   13,036

 

Total current assets

174,159

 

182,084

 
         

Property and equipment, net

116,771

 

59,532

 

Goodwill, net

3,834

 

3,834

 

Restricted cash, non-current

34,889

 

                33,920

 

Other assets, net

                    16,349

 

                     21,028

 
         

Total assets

$                   346,002

 

$                  300,398

 
 

============

 

============

 


LIABILITIES AND STOCKHOLDERS' DEFICIT

       
         

Current liabilities:

       

  Current portion of long-term debt

$                     16,984

 

$                    24,600

 

  Accounts payable

36,689

 

46,339

 

  Accrued compensation and benefits

35,371

 

41,333

 

  Accrued self-insurance obligations

40,393

 

59,029

 

  Other accrued liabilities

                     64,740

 

                      68,160

 
         

Total current liabilities

194,177

 

239,461

 
         

Accrued self-insurance obligations, net of current portion

143,410

 

138,072

 

Long-term debt, net of current portion

91,044

 

54,278

 

Other long-term liabilities

                     17,488

 

                    34,985

 
         

Total liabilities

446,119

 

466,796

 
         

Minority interest

7,058

 

-

 
         

Stockholders' deficit

                 (107,175

)

               ( 166,398

)

         

Total liabilities and stockholders' deficit

$                   346,002

 

$                  300,398

 
 

============

 

============

 

5


SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)

   

For the
Three Months Ended
September 30, 2004

 

For the
Three Months Ended
September 30, 2003

 

(unaudited)

(unaudited)

Total net revenues

 

$                     204,470

 

$                    203,429

 

Costs and expenses:

         

  Operating salaries and benefits

 

122,633

 

126,836

 

  Self insurance for workers' compensation and general and
    professional liability

 


11,395



8,496

 

  Other operating costs

 

42,356

 

40,450

 

  Facility rent expense

 

9,738

 

9,910

 

  General and administrative expenses

 

13,387

 

17,082

 

  Depreciation and amortization

 

2,871

 

1,827

 

  Provision for losses on accounts receivable

 

2,062

 

1,727

 

  Interest, net

2,397

4,084

  Restructuring costs, net

329

4,092

  Loss on sale of assets, net

 

                         1,537

 

                            729

 

Total costs and expenses

 

                     208,705

 

                      215,233

 
           

Loss before income taxes, discontinued operations
  and cumulative effect of change in accounting principle

 


(4,235


)


(11,804


)

Income tax expense

 

                                  -

 

                            175

 

Loss before discontinued operations and
  cumulative effect of change in accounting principle

 


                         (4,235


)


                     (11,979


)

           

Discontinued operations:

         

   Loss from discontinued operations

(3,177

)

(5,965

)

   (Loss) gain on disposal of discontinued operations, net

                        (3,680

)

                      57,054

(Loss) income on discontinued operations

 

                        (6,857

)

                       51,089

 
           

Cumulative effect of change in accounting principle
  net of $0 tax

 


                       11,866

 


                                 -

 
           

Net income

 

$                           774

 

$                     39,110

 
   

============

 

============

 

Basic and diluted income per common

         

   and common equivalent share:

         

   Loss before discontinued operations and cumulative
      effect of change in accounting principle

 


$                        (0.28


)


$                        (1.19


)

   (Loss) income on discontinued operations, net

 

(0.45

)

5.08

 

   Cumulative effect of change in accounting principle

 

                          0.78

 

                                -

 

Net income

 

$                          0.05

 

$                          3.89

 
   

============

 

============

 

Shares used in computing income

         

   per common share:

         

   Basic

 

15,275

 

10,060

 

   Diluted

 

15,354

 

10,060

 

6


SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)

   

For the
Nine Months Ended
September 30, 2004

 

For the
Nine Months Ended
September 30, 2003

 

(unaudited)

(unaudited)

Total net revenues

 

$                       619,609

 

$                    592,224

 

Costs and expenses:

         

  Operating salaries and benefits

 

367,658

 

363,947

 

  Self insurance for workers' compensation and general and
    professional liability

 


31,518



26,243

 

  Other operating costs

 

128,513

 

113,927

 

  Facility rent expense

 

29,792

 

29,504

 

  General and administrative expenses

 

44,991

 

50,232

 

  Depreciation and amortization

 

6,330

 

5,486

 

  Provision for losses on accounts receivable

 

5,584

 

5,291

 

  Interest, net

6,354

14,726

  Restructuring costs, net

1,616

10,012

  (Loss) gain on sale of assets, net

 

1,162

 

(2,225

)

  Gain on extinguishment of debt, net

 

                        (3,734

)

                                 -

 

Total costs and expenses

 

                     619,784

 

                      617,143

 
           

Loss before income taxes, discontinued operations
  and cumulative effect of change in accounting principle

 


(175


)


(24,919


)

Income tax (benefit) expense

 

                        (1,122

)

                            665

 

Income (loss) before discontinued operations and
  cumulative effect of change in accounting principle

 


                            947



                      (25,584


)

           

Discontinued operations:

         

   Loss from discontinued operations

(12,746

)

(18,509

)

   (Loss) gain on disposal of discontinued operations, net

                         (2,418

)

                      58,368

(Loss) income on discontinued operations

 

                       (15,164

)

                       39,859

 
           

Cumulative effect of change in accounting principle
  net of $0 tax

 


                        11,866

 


                                 -

 
           

Net (loss) income

 

$                       (2,351

)

$                     14,275

 
   

============

 

============

 

Basic and diluted (loss) income

         

   per common and common equivalent share:

         

   Income (loss) before discontinued operations and
      cumulative effect of change in accounting principle

 


$                           0.07

 


$                        (2.55


)

   (Loss) income on discontinued operations, net

 

(1.06

)

3.97

 

   Cumulative effect of change in accounting principle

 

                            0.83

 

                                 -

 

Net (loss) income

 

$                         (0.16

)

$                         1.42

 
   

============

 

============

 

Shares used in computing (loss) income

         

   per common share:

         

   Basic

 

14,181

 

10,047

 

   Diluted

 

14,261

 

10,047

 

7


SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)

   

For the
Three Months Ended
September 30, 2004
(unaudited)

 

For the
Three Months Ended
September 30, 2003
(unaudited)

 

Cash flows from operating activities:

         

 Net income

 

$                         774

 

$                 39,110

 
           

Adjustments to reconcile net income to net cash provided by
  (used for) operating activities, including discontinued operations:

         

   Depreciation and amortization

 

2,990

 

1,727

 

   Amortization of favorable and unfavorable lease intangibles

 

(546

)

(2,005

)

   Provision for losses on accounts receivable

 

4,376

 

2,799

 

   Loss on sale of assets, net

 

1,537

 

729

 

   Gain on disposal of discontinued operations, net

 

3,680

 

(57,054

)

   Cumulative effect of change in accounting principle

 

(11,866

)

-

 

   Restricted stock and stock option compensation

 

325

 

202

 

   Other, net

 

119

 

151

 

   Changes in operating assets and liabilities

 

                        7,212

 

                 12,893

 

      Net cash provided by (used for) operating activities before
         reorganization costs

 


8,601

 


(1,448


)

      Net cash paid for reorganization costs

 

                                -

 

                  (1,606

)

      Net cash provided by (used for) operating activities

 

                        8,601

 

                  (3,054

)

Cash flows from investing activities:

         

   Capital expenditures, net

 

(3,383

)

(3,135

)

   Proceeds from sale of assets held for sale

 

1,357

 

77,285

 

   Repayment of long-term notes receivable

 

                            91

 

                        77

 

     Net cash (used for) provided by investing activities

 

                     (1,935

)

                 74,227

 
           

Cash flows from financing activities:

         

   Net payments under Revolving Loan Agreement

 

-

 

(72,113

)

   Long-term debt repayments

 

                         (896

)

                    (776

)

      Net cash provided by (used for) financing activities

 

                         (896

)

               (72,889

)

           

Net increase (decrease) in cash and cash equivalents

 

$                      5,770

 

$                (1,716

)

   

============

 

==========

 

8


SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)

   

For the
Nine Months Ended
September 30, 2004
(unaudited)

 

For the
Nine Months Ended
September 30, 2003
(unaudited)

 

Cash flows from operating activities:

         

 Net (loss) income

 

$                      (2,351

)

$                14,275

 
           

Adjustments to reconcile net (loss) income to net cash (used for)
   provided by operating activities, including discontinued
   operations:

         

   Gain on extinguishment of debt, net

 

(3,734

)

-

 

   Depreciation and amortization

 

6,634

 

7,597

 

   Amortization of favorable and unfavorable lease intangibles

 

(2,770

)

(6,934

)

   Provision for losses on accounts receivable

 

10,324

 

13,104

 

   Gain on sale of assets, net

 

1,162

 

(2,225

)

   Gain on disposal of discontinued operations, net

 

2,418

 

(58,368

)

   Cumulative effect of change in accounting principle

 

(11,866

)

-

 

   Restricted stock compensation and option compensation

 

891

 

742

 

   Other, net

 

1,254

 

617

 

   Changes in operating assets and liabilities

 

                     (24,605

)

                 45,303

 

      Net cash (used for) provided by operating activities before
         reorganization costs

 


(22,643


)


14,111


      Net cash paid for reorganization costs

 

                          (499

)

                 (9,846

)

      Net cash (used for) provided by operating activities

 

                     (23,142

)

                   4,265

 
           

Cash flows from investing activities:

         

   Capital expenditures, net

 

(8,305

)

(13,578

)

   Proceeds from sale of assets held for sale

 

1,357

 

77,637

 

   Repayment of long-term notes receivable

 

                          147

 

                     748

 

      Net cash (used for) provided by investing activities

 

                      (6,801

)

                64,807

 
           

Cash flows from financing activities:

         

   Net payments under Revolving Loan Agreement

 

(13,091

)

(67,969

)

   Long-term debt repayments

 

(5,860

)

           (4,350

)

   Net proceeds from issuance of common stock

 

                     52,266

 

                         -

 

      Net cash provided by (used for) financing activities

 

                     33,315

 

              (72,319

)

           

Net increase (decrease) in cash and cash equivalents

 

$                       3,372

 

$               (3,247

)

   

============

 

==========

 

9


Sun Healthcare Group, Inc.

Reconciliation of Net Income to EBITDA and EBITDAR
(in thousands)

For the

For the

Three Months Ended

Three Months Ended

September 30, 2004

September 30, 2003

(unaudited)

(unaudited)

Total net revenues

$                       204,470

$                      203,429

  Net income

$                               774

$                        39,110

  Income (loss) before discontinued operations and
     cumulative effect of change in accounting principle


$                          (4,235


)


$                      (11,979


)

  Income tax expense

-

175

  Restructuring costs, net

329

4,092

  Loss on sale of assets, net

                            1,537

                             729

  Net segment income (loss)

$                         (2,369

)

$                         (6,983

)

  Interest, net

2,397

4,084

  Depreciation and amortization

                            2,871

                          1,827

EBITDA

$                          2,899

$                        (1,072

)

  Facility rent

                            9,738

                          9,910

EBITDAR

$                        12,637

$                          8,838

=============

=============

EBITDA is defined as earnings before depreciation, amortization, interest expense, interest income, income tax expense (benefit), restructuring costs, net, gain on sale of assets, net, gain (loss) on discontinued operations and cumulative effect of a change in accounting principle. EBITDAR is defined as EBITDA before facility rent expense. EBITDA and EBITDAR are used by management to evaluate financial performance and resource allocation for each entity within the operating units and for the Company as a whole. EBITDA and EBITDAR are commonly used as analytical indicators within the healthcare industry and also serve as measures of leverage capacity and debt service ability. EBITDA and EBITDAR should not be considered as measures of financial performance under generally accepted accounting principles. As the items excluded from EBITDA and EBITDAR are significant components in understanding and assessing financial performance, EBITDA and EBITDAR should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity. Because EBITDA and EBITDAR are not measurements determined in accordance with generally accepted accounting principles and are thus susceptible to varying calculations, EBITDA and EBITDAR as presented may not be comparable to other similarly titled measures of other companies.

10


Sun Healthcare Group, Inc.

Reconciliation of Net (Loss) Income to EBITDA and EBITDAR
(in thousands)

For the

For the

Nine Months Ended

Nine Months Ended

September 30, 2004

September 30, 2003

(unaudited)

(unaudited)

Total net revenues

$                       619,609

$                      592,224

  Net (loss) income

$                          (2,351

)

$                        14,275

  Income (loss) before discontinued operations and
    cumulative effect of change in accounting principle


$                              947



$                      (25,584


)

  Income tax (benefit) expense

(1,122

)

665

  Restructuring costs, net

1,616

10,012

  Loss (gain) on sale of assets, net

                           1,162

                         (2,225

)

Net segment (loss) income

$                          2,603

$                      (17,132

)

  Interest, net

6,354

14,726

  Depreciation and amortization

                            6,330

                          5,486

EBITDA

$                         15,287

$                          3,080

  Facility rent

                          29,792

                        29,504

EBITDAR

$                         45,079

$                        32,584

=============

=============

EBITDA is defined as earnings before depreciation, amortization, interest expense, interest income, income tax expense (benefit), restructuring costs, net, gain on sale of assets, net, gain (loss) on discontinued operations and cumulative effect of a change in accounting principle. EBITDAR is defined as EBITDA before facility rent expense. EBITDA and EBITDAR are used by management to evaluate financial performance and resource allocation for each entity within the operating units and for the Company as a whole. EBITDA and EBITDAR are commonly used as analytical indicators within the healthcare industry and also serve as measures of leverage capacity and debt service ability. EBITDA and EBITDAR should not be considered as measures of financial performance under generally accepted accounting principles. As the items excluded from EBITDA and EBITDAR are significant components in understanding and assessing financial performance, EBITDA and EBITDAR should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity. Because EBITDA and EBITDAR are not measurements determined in accordance with generally accepted accounting principles and are thus susceptible to varying calculations, EBITDA and EBITDAR as presented may not be comparable to other similarly titled measures of other companies.

11


SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

RECONCILIATION OF NET SEGMENT INCOME (LOSS) TO EBITDA AND EBITDAR
($ in thousands)

For the Three Months Ended September 30, 2004
(unaudited)


Inpatient
   Services   


Rehabilitation
Therapy Services


Medical Staffing
       Services     


Home Health
    Services    

Laboratory &
Radiology
     Services     



 Corporate 



Consolidated

Total nonaffiliated net revenues

$      147,993

$              23,693

$            13,240

$               14,887

$            4,655

$                    2

$            204,470

Net segment income (loss)

$          3,439

$                1,480

$                 764

$                1,597

$             (608

)

$             (9,041

)

$              (2,369

)

Interest, net

1,756

21

-

2

-

618

2,397

Depreciation and amortization

         2,419

                    45

                   45

                     141

                    73

                   148

                 2,871

EBITDA

$          7,614

$                1,546

$                 809

$                1,740

$              (535

)

$             (8,275

)

$               2,899

Facility rent

         8,818

                  176

                 188

                     465

                   91

                      -

                 9,738

EBITDAR

$        16,432

$                1,722

$                 997

$               2 ,205

$              (444

)

$            (8,275

)

$             12,637

======

=======

=======

========

=======

=======

========

EBITDA margin

5.1

%

6.5

%

6.1

%

11.7

%

(11.5

)%

1.4

%

EBITDAR margin

11.1

%

7.3

%

7.5

%

14.8

%

(9.5

)%

6.2

%

EBITDA is defined as earnings before depreciation, amortization, interest expense, interest income, income tax expense (benefit), restructuring costs, net, gain on sale of assets, net, gain (loss) on discontinued operations and cumulative effect of a change in accounting principle. EBITDAR is defined as EBITDA before facility rent expense. EBITDA and EBITDAR are used by management to evaluate financial performance and resource allocation for each entity within the operating units and for the Company as a whole. EBITDA and EBITDAR are commonly used as analytical indicators within the healthcare industry and also serve as measures of leverage capacity and debt service ability. EBITDA and EBITDAR should not be considered as measures of financial performance under generally accepted accounting principles. As the items excluded from EBITDA and EBITDAR are significant components in understanding and assessing financial performance, EBITDA and EBITDAR should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity. Because EBITDA and EBITDAR are not measurements determined in accordance with generally accepted accounting principles and are thus susceptible to varying calculations, EBITDA and EBITDAR as presented may not be comparable to other similarly titled measures of other companies.

12


SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

RECONCILIATION OF NET SEGMENT INCOME (LOSS) TO EBITDA AND EBITDAR
($ in thousands)

For the Nine Months Ended September 30, 2004
(unaudited)


Inpatient
   Services   


Rehabilitation
Therapy Services


Medical Staffing
       Services      


Home Health
    Services    

Laboratory &
Radiology
     Services     



 Corporate 



Consolidated

Total nonaffiliated net revenues

$      443,641

$              78,467

$              40,643

$              42,462

$          14,530

$                 46

$          619,609

Net segment income (loss)

$        22,439

$                8,353

$              2,194

$                3,007

$              194

$         (33,584

)

$              2,603

Interest, net

3,418

16

2

33

(46

)

2,931

6,354

Depreciation and amortization

           4,876

                  216

                 137

                  443

              219

                 439

               6,330

EBITDA

$        30,733

$                8,585

$              2,333

$                3,483

$              367

$          (30,214

)

$           15,287

Facility rent

         26,940

                  612

                 604

               1,365

             271

                     -

             29,792

EBITDAR

$        57,673

$                9,197

$              2,937

$                4,848

$              638

$         (30,214

)

$           45,079

======

=======

=======

=======

======

=======

=======

EBITDA margin

6.9

%

10.9

%

5.7

%

8.2

%

2.6

%

2.5

%

EBITDAR margin

13.0

%

11.7

%

7.2

%

11.4

%

4.4

%

7.3

%

EBITDA is defined as earnings before depreciation, amortization, interest expense, interest income, income tax expense (benefit), restructuring costs, net, gain on sale of assets, net, gain (loss) on discontinued operations and cumulative effect of a change in accounting principle. EBITDAR is defined as EBITDA before facility rent expense. EBITDA and EBITDAR are used by management to evaluate financial performance and resource allocation for each entity within the operating units and for the Company as a whole. EBITDA and EBITDAR are commonly used as analytical indicators within the healthcare industry and also serve as measures of leverage capacity and debt service ability. EBITDA and EBITDAR should not be considered as measures of financial performance under generally accepted accounting principles. As the items excluded from EBITDA and EBITDAR are significant components in understanding and assessing financial performance, EBITDA and EBITDAR should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity. Because EBITDA and EBITDAR are not measurements determined in accordance with generally accepted accounting principles and are thus susceptible to varying calculations, EBITDA and EBITDAR as presented may not be comparable to other similarly titled measures of other companies.

13


SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

RECONCILIATION OF NET SEGMENT INCOME (LOSS) TO EBITDA AND EBITDAR
($ in thousands)

For the Three Months Ended September 30, 2003
(unaudited)


Inpatient
   Services   


Rehabilitation
Therapy Services


Medical Staffing
       Services      


Home Health
    Services    

Laboratory &
Radiology
     Services     



 Corporate 



Consolidated

Total nonaffiliated net revenues

$        139,765

$             30,106

$              15,071

$             13,748

$             4,731

$                    8

$           203,429

Net segment income (loss)

$            3,787

$               2,123

$                   786

$                 737

$                438

$           (14,854

)

$             (6,983

)

Interest, net

781

(8

)

-

-

-

3,311

4,084

Depreciation and amortization

             1,545

                    298

                    17

                 121

                  66

               (220

)

               1,827

EBITDA

$            6,113

$                2,413

$                   803

$                 858

$                504

$           (11,763

)

$             (1,072

)

Facility rent

             8,964

                    196

                  262

                 407

                   81

                      -

               9,910

EBITDAR

$         15,077

$                2,609

$                1,065

$               1,265

$               585

$          (11,763

)

$              8,838

=======

========

========

=======

========

=======

=======

EBITDA margin

4.4

%

8.0

%

5.3

%

6.2

%

10.7

%

(0.5)

%

EBITDAR margin

10.8

%

8.7

%

7.1

%

9.2

%

12.4

%

4.3

%

EBITDA is defined as earnings before depreciation, amortization, interest expense, interest income, income tax expense (benefit), restructuring costs, net, gain on sale of assets, net, gain (loss) on discontinued operations and cumulative effect of a change in accounting principle. EBITDAR is defined as EBITDA before facility rent expense. EBITDA and EBITDAR are used by management to evaluate financial performance and resource allocation for each entity within the operating units and for the Company as a whole. EBITDA and EBITDAR are commonly used as analytical indicators within the healthcare industry and also serve as measures of leverage capacity and debt service ability. EBITDA and EBITDAR should not be considered as measures of financial performance under generally accepted accounting principles. As the items excluded from EBITDA and EBITDAR are significant components in understanding and assessing financial performance, EBITDA and EBITDAR should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity. Because EBITDA and EBITDAR are not measurements determined in accordance with generally accepted accounting principles and are thus susceptible to varying calculations, EBITDA and EBITDAR as presented may not be comparable to other similarly titled measures of other companies.

14


SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

RECONCILIATION OF NET SEGMENT INCOME (LOSS) TO EBITDA AND EBITDAR
($ in thousands)

For the Nine Months Ended September 30, 2003
(unaudited)


Inpatient
   Services   


Rehabilitation
Therapy Services


Medical Staffing
       Services      


Home Health
    Services    

Laboratory &
Radiology
     Services     



 Corporate 



Consolidated

Total nonaffiliated net revenues

$        414,069

$              81,511

$           40,585

$           42,033

$           13,941

$                  85

$           592,224

Net segment income (loss)

$           11,680

$              12,318

$                892

$              2,821

$             1,517

$           (46,360

)

$           (17,132

)

Interest, net

2,317

(26

)

-

-

-

12,435

14,726

Depreciation and amortization

          3,955

                   902

                  48

                371

                188

                  22

               5,486

EBITDA

$         17,952

$              13,194

$                940

$              3,192

$             1,705

$          (33,903

)

$              3,080

Facility rent

         26,655

                  588

                736

             1,275

               250

                    -

            29,504

EBITDAR

$         44,607

$              13,782

$             1,676

$             4,467

$             1,955

$          (33,903

)

$            32,584

=======

=======

=======

=======

=======

=======

=======

EBITDA margin

4.3

%

16.2

%

2.3

%

7.6

%

12.2

%

0.5

%

EBITDAR margin

10.8

%

16.9

%

4.1

%

10.6

%

14.0

%

5.5

%

EBITDA is defined as earnings before depreciation, amortization, interest expense, interest income, income tax expense (benefit), restructuring costs, net, gain on sale of assets, net, gain (loss) on discontinued operations and cumulative effect of a change in accounting principle. EBITDAR is defined as EBITDA before facility rent expense. EBITDA and EBITDAR are used by management to evaluate financial performance and resource allocation for each entity within the operating units and for the Company as a whole. EBITDA and EBITDAR are commonly used as analytical indicators within the healthcare industry and also serve as measures of leverage capacity and debt service ability. EBITDA and EBITDAR should not be considered as measures of financial performance under generally accepted accounting principles. As the items excluded from EBITDA and EBITDAR are significant components in understanding and assessing financial performance, EBITDA and EBITDAR should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity. Because EBITDA and EBITDAR are not measurements determined in accordance with generally accepted accounting principles and are thus susceptible to varying calculations, EBITDA and EBITDAR as presented may not be comparable to other similarly titled measures of other companies.

15


SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

RECONCILIATION OF NET SEGMENT INCOME (LOSS) TO EBITDA AND EBITDAR
INPATIENT SERVICES ONLY
($ in thousands)

For the Three Months Ended September 30, 2004
(unaudited)


Inpatient Services-
      Retained     


Inpatient Services-
      Overhead     


Inpatient Services-
 Other Operations 


Subtotal Inpatient
      Services     

Inpatient Services-
Divested/Planned
       Divested       


Total Inpatient
        Services       

Total nonaffiliated net revenues

$              144,524

$                          1

$                      522

$                 145,047

$                   2,946

$                147,993

Net segment income (loss)

$                  6,784

$                   (2,996

)

$                      157

$                    3,945

$                    (506

)

$                   3,439

Interest, net

1,763

-

-

1,763

(7

)

1,756

Depreciation and amortization

                 2,397

                            -

                        10

                     2,407

                       12

                    2,419

EBITDA

$                10,944

$                   (2,996

)

$                      167

$                    8,115

$                   (501

)

$                   7,614

Facility rent

                 8,822

                           -

                        14

                     8,836

                      (18

)

                    8,818

EBITDAR

$                19,766

$                   (2,996

)

$                       181

$                  16,951

$                   (519

)

$                 16,432

========

=========

=========

=========

========

========

EBITDA margin

7.6

%

5.6

%

5.1

%

EBITDAR margin

13.7

%

11.7

%

11.1

%

EBITDA is defined as earnings before depreciation, amortization, interest expense, interest income, income tax expense (benefit), restructuring costs, net, gain on sale of assets, net, gain (loss) on discontinued operations and cumulative effect of a change in accounting principle. EBITDAR is defined as EBITDA before facility rent expense. EBITDA and EBITDAR are used by management to evaluate financial performance and resource allocation for each entity within the operating units and for the Company as a whole. EBITDA and EBITDAR are commonly used as analytical indicators within the healthcare industry and also serve as measures of leverage capacity and debt service ability. EBITDA and EBITDAR should not be considered as measures of financial performance under generally accepted accounting principles. As the items excluded from EBITDA and EBITDAR are significant components in understanding and assessing financial performance, EBITDA and EBITDAR should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity. Because EBITDA and EBITDAR are not measurements determined in accordance with generally accepted accounting principles and are thus susceptible to varying calculations, EBITDA and EBITDAR as presented may not be comparable to other similarly titled measures of other companies.

16


SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

RECONCILIATION OF NET SEGMENT INCOME (LOSS) TO EBITDA AND EBITDAR
INPATIENT SERVICES ONLY
($ in thousands)

For the Nine Months Ended September 30, 2004
(unaudited)


Inpatient Services-
      Retained     


Inpatient Services-
      Overhead     


Inpatient Services-
 Other Operations 


Subtotal Inpatient
      Services     

Inpatient Services-
Divested/Planned
       Divested       


Total Inpatient
        Services       

Total nonaffiliated net revenues

$              432,848

$                          1

$                   1,975

$                434,825

$                  8,817

$                443,641

Net segment income (loss)

$                33,710

$                  (8,755

)

$                       (50

)

24,905

$                 (2,466

)

$                 22,439

Interest, net

2,494

-

962

3,456

(38

)

3,418

Depreciation and amortization

                  4,507

                           -

                      335

                    4,842

                      34

                   4,876

EBITDA

$                40,711

$                  (8,755

)

$                    1,247

$                  33,203

$                 (2,470

)

$                 30,733

Facility rent

                27,916

                           -

                    (915

)

                  27,001

                     (61

)

                 26,940

EBITDAR

$                68,627

$                  (8,755

)

$                      332

$                  60,204

$                 (2,531

)

$                 57,673

=========

=========

=========

=========

=========

=========

EBITDA margin

9.4

%

7.6

%

6.9

%

EBITDAR margin

15.9

%

13.8

%

13.0

%

EBITDA is defined as earnings before depreciation, amortization, interest expense, interest income, income tax expense (benefit), restructuring costs, net, gain on sale of assets, net, gain (loss) on discontinued operations and cumulative effect of a change in accounting principle. EBITDAR is defined as EBITDA before facility rent expense. EBITDA and EBITDAR are used by management to evaluate financial performance and resource allocation for each entity within the operating units and for the Company as a whole. EBITDA and EBITDAR are commonly used as analytical indicators within the healthcare industry and also serve as measures of leverage capacity and debt service ability. EBITDA and EBITDAR should not be considered as measures of financial performance under generally accepted accounting principles. As the items excluded from EBITDA and EBITDAR are significant components in understanding and assessing financial performance, EBITDA and EBITDAR should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity. Because EBITDA and EBITDAR are not measurements determined in accordance with generally accepted accounting principles and are thus susceptible to varying calculations, EBITDA and EBITDAR as presented may not be comparable to other similarly titled measures of other companies.

17


SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

RECONCILIATION OF NET SEGMENT INCOME (LOSS) TO EBITDA AND EBITDAR
INPATIENT SERVICES ONLY
($ in thousands)

For the Three Months Ended September 30, 2003
(unaudited)


Inpatient Services-
      Retained     


Inpatient Services-
      Overhead     


Inpatient Services-
 Other Operations 


Subtotal Inpatient
      Services     

Inpatient Services-
Divested/Planned
       Divested       


Total Inpatient
        Services       

Total nonaffiliated net revenues

$              135,374

$                           -

$                   1,120

$                 136,494

$                   3,271

$               139,765

Net segment income (loss)

$                  8,007

$                  (3,517

)

$                      117

$                     4,607

$                    (820

)

$                   3,787

Interest, net

794

-

-

794

(13

)

781

Depreciation and amortization

                  1,523

                          -

                        10

                     1,533

                        12

                    1,545

EBITDA

$                10,324

$                  (3,517

)

$                      127

$                    6,934

$                    (821

)

$                    6,113

Facility rent

                  8,756

                          -

                        21

                     8,777

                      187

                    8,964

EBITDAR

$                19,080

$                  (3,517

)

$                      148

$                  15,711

$                    (634

)

$                 15,077

========

=========

=========

=========

=========

=========

EBITDA margin

7.6

%

5.1

%

4.4

%

EBITDAR margin

14.1

%

11.5

%

10.8

%

EBITDA is defined as earnings before depreciation, amortization, interest expense, interest income, income tax expense (benefit), restructuring costs, net, gain on sale of assets, net, gain (loss) on discontinued operations and cumulative effect of a change in accounting principle. EBITDAR is defined as EBITDA before facility rent expense. EBITDA and EBITDAR are used by management to evaluate financial performance and resource allocation for each entity within the operating units and for the Company as a whole. EBITDA and EBITDAR are commonly used as analytical indicators within the healthcare industry and also serve as measures of leverage capacity and debt service ability. EBITDA and EBITDAR should not be considered as measures of financial performance under generally accepted accounting principles. As the items excluded from EBITDA and EBITDAR are significant components in understanding and assessing financial performance, EBITDA and EBITDAR should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity. Because EBITDA and EBITDAR are not measurements determined in accordance with generally accepted accounting principles and are thus susceptible to varying calculations, EBITDA and EBITDAR as presented may not be comparable to other similarly titled measures of other companies.

18


SUN HEALTHCARE GROUP, INC. AND SUBSIDIARIES

RECONCILIATION OF NET SEGMENT INCOME (LOSS) TO EBITDA AND EBITDAR
INPATIENT SERVICES ONLY
($ in thousands)

For the Nine Months Ended September 30, 2003
(unaudited)


Inpatient Services-
      Retained     


Inpatient Services-
      Overhead     


Inpatient Services-
 Other Operations 


Subtotal Inpatient
      Retained     

Inpatient Services-
Divested/Planned
       Divested       


Total Inpatient
        Services       

Total net revenues

$                 400,069

$                          -

$                   4,413

$                 404,482

$                   9,587

$               414,069

Net income (loss)

$                  23,037

$               (10,285

)

$                      969

$                   13,721

$                  (2,041

)

$                 11,680

Interest, net

2,354

-

-

2,354

(37

)

2,317

Depreciation and amortization

                    3,886

                           -

                        35

                    3,921

                       34

                   3,955

EBITDA

$                  29,277

$               (10,285

)

$                   1,004

$                  19,996

$                  (2,044

)

$                 17,952

Facility rent

                  26,043

                           -

                       63

                   26,106

                      549

                  26,655

EBITDAR

$                  55,320

$               (10,285

)

$                   1,067

$                   46,102

$                 (1,495

)

$                 44,607

=========

=========

=========

=========

=========

=========

EBITDA margin

7.2

%

4.9

%

4.3

%

EBITDAR margin

13.7

%

11.4

%

10.8

%

EBITDA is defined as earnings before depreciation, amortization, interest expense, interest income, income tax expense (benefit), restructuring costs, net, gain on sale of assets, net, gain (loss) on discontinued operations and cumulative effect of a change in accounting principle. EBITDAR is defined as EBITDA before facility rent expense. EBITDA and EBITDAR are used by management to evaluate financial performance and resource allocation for each entity within the operating units and for the Company as a whole. EBITDA and EBITDAR are commonly used as analytical indicators within the healthcare industry and also serve as measures of leverage capacity and debt service ability. EBITDA and EBITDAR should not be considered as measures of financial performance under generally accepted accounting principles. As the items excluded from EBITDA and EBITDAR are significant components in understanding and assessing financial performance, EBITDA and EBITDAR should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity. Because EBITDA and EBITDAR are not measurements determined in accordance with generally accepted accounting principles and are thus susceptible to varying calculations, EBITDA and EBITDAR as presented may not be comparable to other similarly titled measures of other companies.

19


Sun Healthcare Group, Inc. and Subsidiaries
Selected Operating Statistics
Continuing Operations

 

For the
Three Months Ended
September 30
,

 

For the
Nine Months Ended
September 30
,

 
 

2004

 

2003

 

2004

 

2003

 

Number of licensed beds:

               

     SNF

10,634

 

10,678

 

10,634

 

10,678

 

     Hospitals

192

 

192

 

192

 

192

 
                 

Number of facilities:

               

     SNF

103

 

103

 

103

 

103

 

     Hospitals

3

 

3

 

3

 

3

 
                 

Occupancy %:

               

     SNF - same store

91.2

%

90.7

%

91.1

%

90.6

%

     Hospitals

53.6

%

51.1

%

54.2

%

54.0

%

                 

Payor Mix % based on patient days - Same Store SNF:

               

     Medicare

11.8

%

11.1

%

12.3

%

11.5

%

     Medicaid

64.5

%

65.4

%

64.4

%

65.4

%

     Private and other

23.7

%

23.5

%

23.3

%

23.1

%

                 

Payor Mix % based on patient days - Hospitals:

               

     Medicare

75.9

%

75.4

%

73.4

%

75.7

%

     Medicaid

5.8

%

8.5

%

7.3

%

7.9

%

     Private and other

18.3

%

16.1

%

19.3

%

16.4

%

                 

Payor Mix % based on patient days - Inpatient Services:

               

     Medicare

12.5

%

11.8

%

13.0

%

12.2

%

     Medicaid

63.8

%

64.8

%

63.8

%

64.7

%

     Private and other

23.7

%

23.4

%

23.2

%

23.1

%

                 

Revenue Mix % of revenues - Same Store SNF:

               

     Medicare

25.3

%

24.0

%

26.0

%

24.8

%

     Medicaid

52.2

%

52.9

%

51.8

%

52.2

%

     Private and other

22.5

%

23.1

%

22.2

%

23.0

%

                 

Revenue Mix % of revenues - Hospitals:

               

     Medicare

78.6

%

76.9

%

76.1

%

75.3

%

     Medicaid

5.0

%

7.7

%

6.3

%

7.2

%

     Private and other

16.4

%

15.4

%

17.6

%

17.5

%

                 

Revenue Mix % of revenues - Inpatient Services:

               

     Medicare

29.0

%

27.4

%

29.5

%

28.2

%

     Medicaid

48.9

%

50.0

%

48.6

%

49.2

%

     Private and other

22.1

%

22.6

%

21.9

%

22.6

%

20


Sun Healthcare Group, Inc. and Subsidiaries
Selected Operating Statistics
Continuing Operations

 

For the
Three Months Ended
September 30
,

 

For the
Nine Months Ended
September 30
,

 
 

2004

 

2003

 

2004

 

2003

 

Revenues PPD - Same Store SNF:

               

     Medicare (Part A)

$       314.09

 

$       295.07

 

$      313.25

 

$      295.24

 

     Medicaid

$       130.74

 

$       122.99

 

$      130.98

 

$      121.27

 

     Private and other

$       140.31

 

$       136.56

 

$      141.04

 

$      136.40

 
                 

Revenues PPD - Hospitals:

               

     Medicare (Part A)

$   1,073.20

 

$      951.71

 

$   1,039.28

 

$      910.94

 

     Medicaid

$      932.04

 

$      867.46

 

$      912.45

 

$      867.56

 

     Private and other

$      756.96

 

$   1,189.64

 

$      898.59

 

$      596.71

 
                 

Revenues - Non-affiliated (in thousands):

               

   Inpatient:

               

     Medicare

$      42,877

 

$      38,687

 

$    131,010

 

$    118,980

 

     Medicaid

$      72,380

 

$      69,288

 

$    215,253

 

$    201,716

 

     Private and other

$      32,736

 

$      31,790

 

$      97,378

 

$      93,373

 

            Subtotal

$    147,993

 

$    139,765

 

$    443,641

 

$    414,069

 
                 

     Rehabilitation Therapy

$      23,693

 

$      30,106

 

$      78,467

 

$      81,511

 

     Medical Staffing

13,240

 

15,071

 

40,643

 

40,585

 

     Home Health

14,887

 

13,748

 

42,462

 

42,033

 

     Laboratory and Radiology

        4,655

 

        4,731

 

      14,350

 

       13,941

 

            Subtotal

$      56,475

 

$      63,656

 

$    175,922

 

$    178,070

 
                 

     Other - non-core businesses

                2

 

                8

 

               46

 

               85

 

               Total

$    204,470

 

$    203,429

 

$    619,609

 

$    592,224

 
 

=======

 

=======

 

=======

 

=======

 
                 

Rehab contracts:

               

     Affiliated - continuing

90

 

113

 

90

 

113

 

     Non-Affiliated

311

 

364

 

311

 

364

 
                 

DSO:

               

     Inpatient Services - Same Store SNF

29

 

36

 

29

 

36

 

     Inpatient Services - Hospitals

70

 

92

 

70

 

92

 

     Rehabilitation Therapy

122

 

107

 

122

 

107

 

     Medical Staffing

65

 

61

 

65

 

61

 

     Home Health

61

 

83

 

61

 

83

 

     Laboratory and Radiology

106

 

83

 

106

 

83

 

21